Quest Diagnostics Inc
NYSE:DGX
Quest Diagnostics Inc
NYSE:DGX
Price:
137.55 USD
-0.46%
Market Closed
Updated:
May 2, 2024
Quest Diagnostics Inc
Cash from Investing Activities
|
Quest Diagnostics Inc
Cash from Investing Activities Peer Comparison
Comparables:
DVA
CHE
CVS
CI
LH
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash from Investing Activities
-$1.1B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-21%
|
|
|
DaVita Inc
NYSE:DVA
|
Cash from Investing Activities
-$771.8m
|
CAGR 3-Years
2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
1%
|
|
|
Chemed Corp
NYSE:CHE
|
Cash from Investing Activities
-$63m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-6%
|
|
|
CVS Health Corp
NYSE:CVS
|
Cash from Investing Activities
-$20.9B
|
CAGR 3-Years
-56%
|
CAGR 5-Years
14%
|
CAGR 10-Years
-28%
|
|
|
Cigna Corp
NYSE:CI
|
Cash from Investing Activities
-$5.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash from Investing Activities
-$1.5B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-14%
|
See Also
What is Quest Diagnostics Inc's Cash from Investing Activities?
Cash from Investing Activities
-1.1B
USD
-1.1B
USD
Based on the financial report for Mar 31, 2024, Quest Diagnostics Inc's Cash from Investing Activities amounts to -1.1B USD.
What is Quest Diagnostics Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-21%
-21%
Over the last year, the Cash from Investing Activities growth was -110%. The average annual Cash from Investing Activities growth rates for Quest Diagnostics Inc have been -19% over the past three years , -10% over the past five years , and -21% over the past ten years .
You don't have any saved screeners yet
